Skyepharma
SkyepharmaSkyepharmaSkyepharma

  • Our Company
    • Our Identity
      • Overview
      • History
      • Culture and values
    • Our Commitments
      • Customer experience
      • HSE Commitment
      • Quality Charter
    • Leadership team
    • Our brochures
    • Our videos
  • Development
    • Free prototype application form
    • New Product Introduction
      • NPI Department
      • Technology Transfer
    • Early Stage Program
    • Analytical Development
    • Process Development
      • Pilot Unit
      • QbD Methodology
  • Innovation and Biotech
    • SKYEHUB Bioproduction ®
    • Innovation
  • Manufacturing
    • Bulk manufacturing
    • Technical Capabilities
  • Packaging
    • Pharmaceutical packaging
      • Bottle
      • Blister
      • Stick-pack
    • Serialization and aggregation
  • Support
    • Regulatory affairs
    • Quality Control laboratory
    • Microbiology laboratory
    • Supply Chain
  • Technologies
    • Controlled release technologies
      • Geoclock®
      • Geomatrix®
      • Soctec®
    • Medicated chewing-gum
    • Microfluidizer technology
  • Blog
  • [Carrière]
    • Rejoignez l’équipe Skyepharma !
    • Offres d’emplois
    • Candidatures spontanées
  • Contact
  • Newsletter

Skyepharma CDMO working on data integrity policy to foster its growth

Skyepharma   →  News   →  Skyepharma CDMO working on data integrity policy to foster its growth
28
May
Data integrity Skyepharma
Date 28 May 2020
Categories News

Skyepharma CDMO working on data integrity policy to foster its growth

Data integrity management at Skyepharma

 

Customers are of course attentive to CDMO’s compliance with regulations. But they are even more attentive to the ability of CDMO to go beyond the authorities’ expectations. Data integrity is a good example.

What do we mean by data integrity? The purpose of controlling data integrity in the pharmaceutical industry is to guarantee the robustness of pharmaceutical decisions. Indeed, a lack of control over data integrity frequently reflects a more global lack of control over product quality.

From a practical point of view, that means ensuring that the data recorded corresponds exactly to reality, that there is no alteration of these data and data traceability.

This traceability of GMP data allows us to make the right decisions and ensure patient safety by guaranteeing a safe and quality drug.

 

All employees are involved

 

At Skyepharma a specific expert working group has been set up to integrate data integrity in our processes. Apart from this expert group, all employees received appropriate training with a specific focus on data traceability. It is now fully integrated in Skyepharma values and culture.

“Data integrity process is fully assimilated at Skyepharma. This process makes it possible to easily integrate new IT systems or equipments and responds to the requirements of customers and health authorities” said Ludivine Laugerette, Head of Technical Quality Assurance Department at Skyepharma.

An exhaustive inventory of all systems and equipment has been carried out to ensure compliance. The priority systems have been processed, the other systems are being changed and integrated into the new traceability process.

This assessment allows us to meet the ALCOA+ standard (Attributable Legible Contemporaneous Original Accurate + Complete Consistent Enduring Available Data).

“This project was a very challenging one, we succeeded thanks to our team spirit and to the strong implication of all the staff. People are proud to have taken up this challenge!” Says Xavier Mathiot, Skyepharma Quality Director.

You liked this reading? Feel free to contact us !









    Share this post

    LATESTS POSTS

    News
    • Bigger Thinking for nanomedicines 28 March 2023
    • Skyepharma: the specialized CDMO growing in double digits 24 January 2023
    • Apporter de l’innovation dans la sous-traitance pharmaceutique 29 March 2022
    • Comment Skyepharma entretient l’innovation ? 15 February 2022
    • Skyepharma et MaaT Pharma annoncent leur partenariat pour lancer la première usine française de production exclusivement dédiée aux biothérapies issues du microbiote 9 February 2022

    Recent Posts

    • OFFRE STAGE DE 4 à 6 mois (H/F) EST LYONNAIS
    • TECHNICIEN CONTRÔLE QUALITE (H/F) EST LYONNAIS
    • Comptable fournisseur (H/F) EST LYONNAIS CDD 2 MOIS
    • ALTERNANCE Conducteur de ligne de conditionnement (H/F) EST LYONNAIS
    • Responsable Affaires Réglementaires et pharmacovigilance CDD 6 MOIS (H/F) EST LYONNAIS
    Privacy and Cookie Policy - Terms and Conditions - Legal Notice - Copyright © 2021 Skyepharma Production SAS. All rights reserved.